Skip to main content

Summary

Cutaneous manifestations of Sjogren’s syndrome (SS) include:

  • Dry skin (xerosis)

  • Vasospastic disorders ranging from Raynaud’s to acrocyanosis

  • Macular, papular and vesicular rashes

  • Infections such as varicella zoster

  • Palpable and non-palpable purpura due vasculitis, and

  • Embolic lesions and thrombotic lesions

  • Acute or chronic thrombosis with lymphedema

  • Other associated skin conditions including urticaria or allergic skin eruptions

Complaints of dry skin occur in about 50% of SS patients. It is unclear whether or not the xerosis is due to infiltrate of the eccrine or sebaceous glands, or dysfunctional response of the residual glands. In many biopsies from SS patients, dryness of the skin has been associated with lymphocytic infiltrates in the eccrine glands. Similar to SLE patients, antibody and complement fixation is often detected clinically “normal” skin.

However, the extent of dryness of the skin and the clinical appearance termed “xerosis” is often more severe than that expected for the degree of lymphocytic infiltration (and glandular destruction).

A common finding on deeper skin biopsy is “non-specific perivascular lymphocytic infiltrates.” Immuno-histologic studies have also indicated an increase in peri-vascular dendritic cells of both the mesenchymal and Plasmacytoid types. These histologic findings on SS skin biopsy are so common that the pathologist may often only mentions them “in passing,” while they emphasize that no leukocytoclastic vasculitic changes were present. But these “perivascular” lymphocytic (and dendritic) cell infiltrates may be the crucial factor in xerosis of SS.

Treatment of SS is generally symptomatic, with most patients requiring treatment only for dryness. Adequate explanation is essential; many subjects, for example, may not realize that their central heating or air conditioning creates a drying environment or that a windy day is likely to make their eyes dryer. Simple measures such as humidifiers, sips of water, chewing gums, and simple replacement tears will be adequate in the majority of subjects. The rest should be told of the wide range of artificial fluids available and encouraged to try several different formulations.

Treatment of other manifestations of SS has been influenced by our treatment of other connective tissue diseases. The most serious (and fortunately rare) complications such as vasculitis and neurologic disease probably require immunosuppression with drugs such as cyclophosphamide, as in systemic lupus erythematosus.

Because many lupus symptoms mimic other illnesses, are sometimes vague and may come and go, lupus can be difficult to diagnose. Diagnosis is usually made by a careful review of a person’s entire medical history coupled with an analysis of the results obtained in routine laboratory tests and some specialized tests related to immune status. Currently, there is no single laboratory test that can determine whether a person has lupus or not. To assist the physician in the diagnosis of lupus, the American Rheumatism Association issued a list of 11 symptoms or signs that help distinguish lupus from other diseases. A person should have four or more of these symptoms to suspect lupus. The symptoms do not all have to occur at the same time

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alexander, E.L., T.T. Provost (1983) Cutaneous manifestations of primary Sjögren’s syndrome: a reflection of vasculitis and association with anti-Ro (SSA) antibodies. J. Invest. Dermatol. 80:386–391

    Article  PubMed  CAS  Google Scholar 

  • Alexander, E.L., K. Malinow, J.E. Lejewski, M.S. Jerdan, T.T. Provost, and G.E. Alexander. (1986) Primary Sjögren’s syndrome with central nervous system disease mimicking multiple sclerosis. Annals of Internal Medicine 104:323–330

    PubMed  CAS  Google Scholar 

  • Alexander, E., T.T. Provost (1987) Sjögren’s syndrome. Association of cutaneous vasculitis with central nervous system disease. Arch. Dermatol. 123:801–810

    Article  PubMed  CAS  Google Scholar 

  • Allison, P. J., D. Locker, J. S. Feine (1999) The relationship between dental status and health-related quality of life in upper aerodigestive tract cancer patients. Oral Oncol 35(2):138–143

    Article  PubMed  CAS  Google Scholar 

  • Andonopoulos, A. P., J. Christodoulou, C. Ballas, A. Bounas, D. Alexopoulos (1998) Autonomic cardiovascular neuropathy in Sjogren’s syndrome. A controlled study. J Rheumatol 25(12):2385–2388

    PubMed  CAS  Google Scholar 

  • Aragona, P., A. Stilo, F. Ferreri, M. Mobrici (2005) Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjogren’s syndrome patients. Eye 19(5):535–539

    Article  PubMed  CAS  Google Scholar 

  • Arbuckle, M. R., M. T. McClain, M. V. Rubertone, R. H. Scofield, G. J. Dennis, J. A. James, J. B. Harley (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349(16):1526–1533

    Article  PubMed  CAS  Google Scholar 

  • Asherson, R.A., H.M. Fei, H.L. Staub, M.A. Khamashta, G.R.V. Hughes, R.I. Fox (1992) Antiphospholipid antibodies and HLA associations in primary Sjögren’s syndrome. Ann Rheum Dis 51:495–498

    Article  PubMed  CAS  Google Scholar 

  • Banting, D. W., A. Papas, D. C. Clark, H. M. Proskin, M. Schultz, R. Perry (2000) The effectiveness of 10% chlorhexidine varnish treatment on dental caries incidence in adults with dry mouth. Gerodontology 17(2):67–76

    Article  PubMed  CAS  Google Scholar 

  • Barendregt, P. J., M. J. van Den Bent, V. J. van Raaij-Van Den Aarssen, A. H. van Den Meiracker, C. J. Vecht, G. L. van Der Heijde, H. M. Markusse (2001) Involvement of the peripheral nervous system in primary Sjogren’s syndrome. Ann Rheum Dis 60(9):876–881

    PubMed  CAS  Google Scholar 

  • Battista, G., M. Zompatori, V. Poletti, R. Canini (2003) Thoracic manifestations of the less common collagen diseases. A pictorial essay. Radiol Med (Torino) 106(5–6):445–451; quiz 52–3

    Google Scholar 

  • Belafsky, P. C., G. N. Postma (2003) The laryngeal and esophageal manifestations of Sjogren’s syndrome. Curr Rheumatol Rep 5(4):297–303

    Article  PubMed  Google Scholar 

  • Belin, C., C. Moroni, N. Caillat-Vigneron, M. Debray, M. Baudin, J. L. Dumas, J. L. Moretti, P. Delaporte, L. Guillevin (1999) Central nervous system involvement in Sjogren’s syndrome: evidence from neuropsychological testing and HMPAO-SPECT [In Process Citation]. Ann Med Interne (Paris) 150(8):598–604

    CAS  Google Scholar 

  • Ben-Chetrit, E., R.I. Fox, E.M. Tan (1990) Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren’s syndrome. Arthritis & Rheum. 33:349–355

    Article  CAS  Google Scholar 

  • Berdoulay, A., R. V. English, B. Nadelstein (2005) Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. Vet Ophthalmol 8(4):225–232

    Article  PubMed  CAS  Google Scholar 

  • Bergdahl, J., M. Bergdahl (2001) Environmental illness: evaluation of salivary flow, symptoms, diseases, medications, and psychological factors. Acta Odontol Scand 59(2): 104–110

    Article  PubMed  CAS  Google Scholar 

  • Bernacchi, E., L. Amato, A. Parodi, F. Cottoni, P. Rubegni, O. De Pita, M. Papini, A. Rebora, S. Bombardieri, P. Fabbri (2004) Sjogren’s syndrome: a retrospective review of the cutaneous features of 93 patients by the Italian Group of Immunodermatology. Clin Exp Rheumatol 22(1):55–62

    PubMed  CAS  Google Scholar 

  • Bernstein, H.N (1991) Ocular safety of hydroxychloroquine. Annals Ophthalmol 23:292–296

    CAS  Google Scholar 

  • Beroukas, D., R. Goodfellow, J. Hiscock, R. Jonsson, T. P. Gordon, S. A. Waterman (2002) Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjogren’s syndrome. Lab Invest 82(2):203–210

    PubMed  CAS  Google Scholar 

  • Beroukas, D., J. Hiscock, R. Jonsson, S. A. Waterman, T. P. Gordon (2001) Subcellular distribution of aquaporin 5 in salivary glands in primary Sjogren’s syndrome. Lancet 358(9296):1875–1876

    Article  PubMed  CAS  Google Scholar 

  • Bloch, K.J., W.W. Buchanan, M.J. Wohl, J.J. Bunim (1956) Sjögren’s syndrome: A clinical, pathological and serological study of 62 cases. Medicine (Baltimore) 44:187–231

    Google Scholar 

  • Bolstad, A. I., H. G. Eiken, B. Rosenlund, M. E. Alarcon-Riquelme, R. Jonsson (2003) Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjogren’s syndrome. Arthritis Rheum 48(1):174–185

    Article  PubMed  CAS  Google Scholar 

  • Bonafede, R. P., D. C. Downey, R. M. Bennett (1995) An association of fibromyalgia with primary Sjogren’s syndrome: a prospective study of 72 patients. J Rheumatol 22(1):133–136

    PubMed  CAS  Google Scholar 

  • Bone, R C, R I Fox, F V Howell, R Fantozzi (1985) Sjögren’s syndrome: New immunologic assessments for a persistent clinical problem. Laryngoscope 95:295–299

    Article  PubMed  CAS  Google Scholar 

  • Borda, E., C. P. Leiros, S. Bacman, A. Berra, L. Sterin-Borda (1999) Sjogren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation. Int J Cardiol 70(1):23–32

    Article  PubMed  CAS  Google Scholar 

  • Bowman, S. J (2002) Collaborative research into outcome measures in Sjogren’s syndrome. Update on disease assessment. Scand J Rheumatol Suppl (116):23–27

    Google Scholar 

  • Bowman, S. J., G. H. Ibrahim, G. Holmes, J. Hamburger, J. R. Ainsworth (2004) Estimating the prevalence among Caucasian women of primary Sjogren’s syndrome in two general practices in Birmingham, UK. Scandinavian J Rheumatol 33(1):39–43

    Article  CAS  Google Scholar 

  • Castillo, J. L. and P. Milgrom (2004) Fluoride release from varnishes in two in vitro protocols. J Am Dent Assoc 135(12):1696–1699

    PubMed  CAS  Google Scholar 

  • Castillo, J. L., P. Milgrom, E. Kharasch, K. Izutsu, M. Fey (2001) Evaluation of fluoride release from commercially available fluoride varnishes. J Am Dent Assoc 132(10): 1389–1392; 459–60

    PubMed  CAS  Google Scholar 

  • Chan, E K L, K F Sullivan, R I Fox, E M Tan (1989) Sjögren’s syndrome nuclear antigen B (La): cDNA cloning, structural domains, and autoepitopes. J Autoimmun 2:321–327

    Article  PubMed  CAS  Google Scholar 

  • Chatterjee, S (2004) Severe interstitial pneumonitis associated with infliximab therapy. Scand J Rheumatol 33(4):276–277

    Article  PubMed  CAS  Google Scholar 

  • Christensen, L. B., P. E. Petersen, J. J. Thorn, M. Schiodt (2001) Dental caries and dental health behavior of patients with primary Sjogren syndrome. Acta Odontol Scand 59(3): 116–120

    Article  PubMed  CAS  Google Scholar 

  • Cimaz, R., A. Casadei, C. Rose, J. Bartunkova, A. Sediva, F. Falcini, P. Picco, M. Taglietti, F. Zulian, R. Ten Cate, F. R. Sztajnbok, P. V. Voulgari, A. A. Drosos (2003) Primary Sjogren syndrome in the paediatric age: a multicentre survey. Eur J Pediatr 162(10):661–665

    Article  PubMed  Google Scholar 

  • Cohen, Y., A. Polliack, and A. Nagler (2003) Treatment of Refractory Autoimmune Diseases with Ablative Immunotherapy Using Monoclonal Antibodies and/or High Dose Chemotherapy with Hematopoietic Stem Cell Support. Curr Pharm Des 9(3):279–288

    Article  PubMed  CAS  Google Scholar 

  • Collin, P., A. L. Karvonen, M. Korpela, P. Laippala, and H. Helin (1997) Gastritis classified in accordance with the Sydney system in patients with primary Sjogren’s syndrome. Scand J Gastroenterol 32(2):108–111

    Article  PubMed  CAS  Google Scholar 

  • Collin, P., T. Reunala, M. Rasmussen, S. Kyronpalo, E. Pehkonen, P. Laippala, and M. Maki (1997) High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol 32(11):1129–1133

    Article  PubMed  CAS  Google Scholar 

  • Constantopoulos, S. H., E. V. Tsianos, H. M. Moutsopoulos (1992) Pulmonary and gastrointestinal manifestations of Sjogren’s syndrome. Rheum Dis Clin North Am 18(3):617–635

    PubMed  CAS  Google Scholar 

  • D’Arbonneau, F., S. Ansart, R. Le Berre, M. Dueymes, P. Youinou, and Y. L. Pennec (2003) Thyroid dysfunction in primary Sjogren’s syndrome: a long-term followup study. Arthritis Rheum 49(6):804–809

    Article  PubMed  Google Scholar 

  • Dabadghao, S., A. Aggarwal, P. Arora, R. Pandey, R. Misra (1995) Glomerulonephritis leading to end stage renal disease in a patient with primary Sjogren syndrome. Clin Exp Rheumatol 13(4):509–511

    PubMed  CAS  Google Scholar 

  • Dalavanga, Y.A., B. Detrick, J.J. Hooks, A.A. Drosos, H.M. Moutsopoulos (1990) Effect of cyclosporin A (CyA) on the immunopathological lesion of the minor salivary glands from patients with Sjögren’s syndrome. Annals of the Rheu. Diseases 46:89–92

    Article  Google Scholar 

  • Daniels, T.E.(1984) Labial salivary gland biopsy in Sjögren’s syndrome. Arthritis Rheum. 27:147–156

    Google Scholar 

  • Daniels, T, Fox, PC (1992) Salivary and Oral Components of Sjogren’s Syndrome. Rheum Clinics NA 18:571–583

    CAS  Google Scholar 

  • Daniels, T. E., P. C. Fox (1992) Salivary and oral components of Sjogren’s syndrome. Rheum Dis Clin North Am 18(3):571–589

    PubMed  CAS  Google Scholar 

  • Daniels, T. E (2000) Evaluation, differential diagnosis, and treatment of xerostomia. J Rheumatol Suppl 61:6–10

    PubMed  CAS  Google Scholar 

  • Daniels, T. E., A. J. Wu (2000) Xerostomia — clinical evaluation and treatment in general practice. J Calif Dent Assoc 28(12):933–941

    PubMed  CAS  Google Scholar 

  • de Seze, J., D. Devos, G. Castelnovo, P. Labauge, S. Dubucquoi, T. Stojkovic, D. Ferriby, P. Vermersch (2001) The prevalence of Sjogren syndrome in patients with primary progressive multiple sclerosis. Neurology 57(8):1359–1363

    PubMed  Google Scholar 

  • Deheinzelin, D., V. L. Capelozzi, R. A. Kairalla, J. V. Barbas Filho, P. H. Saldiva, C. R. de Carvalho (1996) Interstitial lung disease in primary Sjogren’s syndrome. Clinical-pathological evaluation and response to treatment [see comments]. Am J Respir Crit Care Med 154(3 Pt 1):794–799

    PubMed  CAS  Google Scholar 

  • Delalande, S., J. de Seze, A. L. Fauchais, E. Hachulla, T. Stojkovic, D. Ferriby, S. Dubucquoi, J. P. Pruvo, P. Vermersch, P. Y. Hatron (2004) Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 83(5):280–291

    Article  Google Scholar 

  • Fei, H.M., H.-I. Kang, S. Scharf, H. Erlich, C. Peebles, R.I. Fox (1991) Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjögren’s syndrome and autoantibody SS-B production. J. Clin. Lab. Analysis 5:382–391

    Article  CAS  Google Scholar 

  • Feist, E., U. Kuckelkorn, T. Dorner, H. Donitz, S. Scheffler, F. Hiepe, P. M. Kloetzel, G. R Burmester (1999) Autoantibodies in primary Sjogren’s syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 42(4):697–702

    Article  PubMed  CAS  Google Scholar 

  • Fisher, A. 1999. Muscarinic Receptor Agonists in Alzheimer’s Disease. CNS Drugs 12:197–214

    Google Scholar 

  • Fisher, A., E. Heldman, D. Gurwitz, R. Haring, Y. Karton, H. Meshulam, Z. Pittel, D. Marciano, R. Brandeis, E. Sadot, Y. Barg, R. Pinkas-Kramarski, Z. Vogel, I. Ginzburg, T. A. Treves, R. Verchovsky, S. Klimowsky, A. D. Korczyn (1996) M1 agonists for the treatment of Alzheimer’s disease. Novel properties and clinical update. Ann N YAcad Sci 777(2):189–196

    Article  CAS  Google Scholar 

  • Foster, E. N., K. K. Nguyen, R. A. Sheikh, T. P. Prindiville (2005) Crohn’s disease associated with Sweet’s syndrome and Sjogren’s syndrome treated with Infliximab. Clin Dev Immunol 12(2):145–149

    Article  PubMed  Google Scholar 

  • Fox, R I, D A Carson, P Chen, S Fong (1986) Characterization of a cross reactive idiotype in Sjögren’s syndrome. Scandinavian journal of rheumatology 561:83–88

    Google Scholar 

  • Fox, R I, P P Chen, D A Carson, S Fong (1986) Expression of a cross reactive idiotype on rheumatoid factor in patients with Sjögren’s syndrome. J Immunol 136:477–483

    PubMed  CAS  Google Scholar 

  • Fox, R I, C Robinson, J Curd, P Michelson, R Bone, F V Howell (1986) First international symposium on Sjögren’s syndrome: Suggested criteria for classification. Scandinavian journal of rheumatology 562:28–30

    Google Scholar 

  • Fox, R. I., F. V. Howell (1986) Oral problems in patients with Sjögren’s syndrome. Scandinavian journal of rheumatology S61:194–200

    Google Scholar 

  • Fox, R I, E Chan, L Benton, S Fong, M Friedlaender, F V Howell (1988) Treatment of primary Sjögren’s syndrome with hydroxychloroquine. Amer J Med 85:62–67

    Article  PubMed  CAS  Google Scholar 

  • Fox, R. I., R. Dixon, V. Guarrasi, S. Krubel (1996) Treatment of primary Sjogren’s syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 5Suppl 1:S31–S36

    Article  PubMed  Google Scholar 

  • Fox, R (1997) Sjogren’s syndrome: Progress and controversies. Med Clin NA 17:441–534

    Google Scholar 

  • Fox, R. I., J. Tornwall, P. Michelson (1999) Current issues in the diagnosis and treatment of Sjogren’s syndrome. Curr Opin Rheumatol 11(5):364–371

    Article  PubMed  CAS  Google Scholar 

  • Fox, R. I (2000) Sjogren’s syndrome: current therapies remain inadequate for a common disease. Expert Opin Investig Drugs 9(9):2007–2016

    Article  PubMed  CAS  Google Scholar 

  • Fox, R. I., Y. Konttinen, A. Fisher (2001) Use of muscarinic agonists in the treatment of Sjogren’s syndrome. Clin Immunol 101(3):249–263

    Article  PubMed  CAS  Google Scholar 

  • Fox, R. I., M. Stern (2002) Sjogren’s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand J Rheumatol Suppl (116):3–13

    Google Scholar 

  • Franceschini, F., P. Calzavara-Pinton, M. Quinzanini, I. Cavazzana, L. Bettoni, C. Zane, F. Facchetti, P. Airo, D. P. McCauliffe, R. Cattaneo (1999) Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. Lupus 8(3):215

    Article  PubMed  CAS  Google Scholar 

  • Fulop, M., M. Mackay (2004) Renal tubular acidosis, Sjogren syndrome, and bone disease. Arch Intern Med 164(8):905–909

    Article  PubMed  Google Scholar 

  • Gaither, K.K., O.W. Fox, H. Yamagata, M.J. Mamula, M. Reichlin, J.B. Harley (1987) Implications of anti-Ro/Sjögren’s syndrome A antigen autoantibody in normal sera for autoimmunity. J. Clin. Invest. 79:841–846

    Article  PubMed  CAS  Google Scholar 

  • Gamron, S., G. Barberis, C. M. Onetti, I. Strusberg, E. Hliba, G. Martellotto, H. G. Jara, A. M. Sesin (2000) Mesangial nephropathy in Sjogren’s syndrome. Scandinavian journal of rheumatology 29(1):65–67

    Article  PubMed  CAS  Google Scholar 

  • Grant, I. A., G. G. Hunder, H. A. Homburger, P. J. Dyck (1997) Peripheral neuropathy associated with sicca complex. Neurology 48(4):855–862

    PubMed  CAS  Google Scholar 

  • Gross, W. L (1999) New concepts in treatment protocols for severe systemic vasculitis. Curr Opin Rheumatol 11(1):41–46

    Article  PubMed  CAS  Google Scholar 

  • Gyongyosi, M., G. Pokorny, Z. Jambrik, L. Kovacs, A. Kovacs, E. Makula, M. Csanady (1996) Cardiac manifestations in primary Sjogren’s syndrome. Ann Rheum Dis 55(7):450–454

    Article  PubMed  CAS  Google Scholar 

  • Gyulai, R., M. Kiss, M. Mehravaran, L. Kovacs, G. Pokorny, S. Husz, A. Dobozy (2002) Atypical autoimmune blistering dermatosis associated with Sjogren’s syndrome. Acta Derm Venereol 82(6):462–464

    Article  PubMed  CAS  Google Scholar 

  • Haimowitz, J. E., D. P. McCauliffe, J. Seykora, V. P. Werth (2000) Annular erythema of Sjogren’s syndrome in a white woman. J Am Acad Dermatol 42(6): 1069–1072

    Article  PubMed  CAS  Google Scholar 

  • Hamano, T (2005) Lacrimal duct occlusion for the treatment of dry eye. Semin Ophthalmol 20(2):71–74

    Article  PubMed  Google Scholar 

  • Hamilton, R.G., J.B. Harley, W. B. Bias, al et (1988) Two Ro (SS-A) autoantibody responses in systemic lupus erythematous. Arthritis Rheum. 31:446–505

    Article  Google Scholar 

  • Harley, J.B., E.L. Alexander, W.B. Bias, O.F. Fox, T.T. Provost, M. Richlin, H. Yanagata, F.C. Arnett (1986) Anti-Ro (SS-A) and Anti-La (SS-B) in patients with Sjögren’s syndrome. Arthritis Rheum 29:196–206

    Article  PubMed  CAS  Google Scholar 

  • Hay, K. D, R. P. Morton (2003) The efficacy of casein phosphoprotein-calcium phosphate complex (DC-CP) [Dentacal] as a mouth moistener in patients with severe xerostomia. N Z Dent J 99(2):46–48

    PubMed  CAS  Google Scholar 

  • Hay, K. D., W. M. Thomson (2002) A clinical trial of the anticaries efficacy of casein derivatives complexed with calcium phosphate in patients with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93(3):271–275

    Article  PubMed  Google Scholar 

  • Heinlen, L. D., M. T. McClain, X. Kim, D. R. Quintero, J. A James, J. B. Harley, R. H. Scofield (2003) Anti-Ro and anti-nRNP response in unaffected family members of SLE patients. Lupus 12(4):335–337

    Article  PubMed  Google Scholar 

  • Illei, G. G., E. Tackey, L. Lapteva, P. E. Lipsky (2004) Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum 50(7):2048–2065

    Article  PubMed  CAS  Google Scholar 

  • Invernizzi, P., P. M. Battezzati, A. Crosignani, P. Zermiani, M. Bignotto, N. Del Papa, M. Zuin, M. Podda (1998) Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin Exp Immunol 114(3):448–454

    Article  PubMed  CAS  Google Scholar 

  • Isidor, F., K. Brondum, H. J. Hansen, J. Jensen, S. Sindet-Pedersen (1999) Outcome of treatment with implant-retained dental prostheses in patients with Sjogren syndrome. Int J Oral Maxillofac Implants 14(5):736–743

    PubMed  CAS  Google Scholar 

  • Ito, Y., N. Kanda, H. Mitsui, T. Watanabe, S. Kobayashi, S. Murayama, K. Tamaki (1999) Cutaneous manifestations of Sjogren’s syndrome associated with myasthenia gravis [letter]. Br J Dermatol 141(2):362–363

    Article  PubMed  CAS  Google Scholar 

  • Johnson, E. O., P. G. Vlachoyiannopoulos, F. N. Skopouli, A. G. Tzioufas, H. M. Moutsopoulos (1998) Hypofunction of the stress axis in Sjogren’s syndrome. J Rheumatol 25(8):1508–1514

    PubMed  CAS  Google Scholar 

  • Jonsson, R., T. P. Gordon, Y. T. Konttinen (2003) Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjogren’s syndrome. Curr Rheumatol Rep 5(4):311–316

    Article  PubMed  Google Scholar 

  • Josephs, S.F., A. Buchbinder, H.Z. Streicher, D.V. Ablashi, S.Z. Salahuddin, H.G. Guo, R.F. Krueger, R.I. Fox, R.C. Gallo (1988) Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B-cell lymphoma tissues of three patients. Leukemia 2:132–135

    PubMed  CAS  Google Scholar 

  • Jubert, C., A. Cosnes, T. Clerici, P. Gaulard, P. Andre, J. Revuz, M. Bagot (1993) Sjogren’s syndrome and cutaneous B cell lymphoma revealed by anetoderma. Arthritis Rheum 36(1): 133–134

    Article  PubMed  CAS  Google Scholar 

  • Kamel, O. W., M. van de Rijn, L. M. Weiss, G. J. Del Zoppo, P. K. Hench, B. A. Robbins, P. G. Montgomery, R. A. Warnke, R. F. Dorfman (1993) Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328(18):1317–1321

    Article  PubMed  CAS  Google Scholar 

  • Kassan, S.S., T.L. Thomas, H.M. Moutsopoulos, R. Hoover, R.P. Kimberly, D.R. Budman, J. Costa, J.L. Decker, T.M. Chused (1978) Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med. 89:888–892

    PubMed  CAS  Google Scholar 

  • Katayama, I., T. Yamamoto, K. Otoyama, T. Matsunaga, K. Nishioka (1994) Clinical and immunological analysis of annular erythema associated with Sjogren syndrome. Dermatology 189Suppl 1:14–17

    Article  PubMed  Google Scholar 

  • Katayama, Y., K. Kohriyama (2001) Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases. J Rheumatol 28(2):288–291

    PubMed  CAS  Google Scholar 

  • Katelaris, C. H. (2005) Pilocarpine for Dry Mouth and Dry Eye in Sjogren’s Syndrome. Curr Allergy Asthma Rep 5(4):321

    Article  Google Scholar 

  • Kaufman, K. M., M. Y. Kirby, M. T. McClain, J. B. Harley, J. A. James (2001) Lupus autoantibodies recognize the product of an alternative open reading frame of SmB/B’. Biochem Biophys Res Commun 285(5): 1206–1212

    Article  PubMed  CAS  Google Scholar 

  • Kim, B. M., S. S. Osmanovic, D. P. Edward (2005) Pyogenic granulomas after silicone punctal plugs: a clinical and histopathologic study. Am J Ophthalmol 139(4):678–684

    Article  PubMed  Google Scholar 

  • Kim, E. A., K. S. Lee, T. Johkoh, T. S. Kim, G. Y. Suh, O. J. Kwon, J. Han (2002) Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 22 Spec No:S151–S165

    Article  PubMed  Google Scholar 

  • Konishi, M., Y. Ohosone, M. Matsumura, Y. Oyamada, K. Yamaguchi, Y. Kawahara, T. Mimori, Y. Ikeda (1997) Mixed-cryoglobulinemia associated with cutaneous vasculitis and pulmonary symptoms. Intern Med 36(1):62–67

    Article  PubMed  CAS  Google Scholar 

  • Konttinen, Y. T., L. Kasna-Ronkainen (2002) Sjogren’s syndrome: viewpoint on pathogenesis. One of the reasons I was never asked to write a textbook chapter on it. Scand J Rheumatol Suppl (116):15–22

    Google Scholar 

  • Konttinen, Y.T., M. Hukkanen, P. Kemppinen, M. Segerberg, al. et. (1992) Peptide-containing nerves in labial salivary glands in Sjögren’s syndrome. Arthritis Rheum 35:815–820

    Article  PubMed  CAS  Google Scholar 

  • Kruize, A., R. Hene, C. Kallenberg, O. van Bijsterveld, A. van der Heide, L. Kater, J. Bijlsma (1993) Hydroxychloroquine treatment for primary Sjögren’s syndrome: a two year double blind crossover trial. Ann Rheum Dis 52:360–364

    Article  PubMed  CAS  Google Scholar 

  • Kyle, R., G. Gleich, E. Baynd, and et a. (1971) Benign hyperglobuliemic purpura of Waldenstrom. Medicine (Baltimore) 50:113–123

    CAS  Google Scholar 

  • Lass, P., J. Krajka-Lauer, M. Homziuk, B. Iwaszkiewicz-Bilikiewicz, M. Koseda, M. Hebanowski, P. Lyczak (2000) Cerebral blood flow in Sjogren’s syndrome using 99Tcm-HMPAO brain SPET. Nucl Med Commun 21(1):31–35

    Article  PubMed  CAS  Google Scholar 

  • Leppilahti, M., T. L. Tammela, H. Huhtala, P. Kiilholma, K. Leppilahti, A. Auvinen (2003) Interstitial cystitis-like urinary symptoms among patients with Sjogren’s syndrome: a population-based study in Finland. Am J Med 115(1):62–65

    Article  PubMed  Google Scholar 

  • Li, J. M., A. C. Horsfall, R. N. Maini (1995) Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin — a role in the pathogenesis of congenital heart block? Clin Exp Immunol 99(3):316–324

    Article  PubMed  CAS  Google Scholar 

  • Lightfoot, R. (1997) Cost Effective use of Laboratory Tests in Rheumatology. Bul Rheum Dis 46:1–3

    Google Scholar 

  • Lindvall, B., A. Bengtsson, J. Ernerudh, P. Eriksson (2002) Subclinical myositis is common in primary Sjogren’s syndrome and is not related to muscle pain. J Rheumatol 29(4):717–725

    PubMed  Google Scholar 

  • Lwin, C. T., M. Bishay, R. G. Platts, D. A. Booth, S. J. Bowman (2003) The assessment of fatigue in primary Sjogren’s syndrome. Scandinavian journal of rheumatology 32(1):33–37

    Article  PubMed  Google Scholar 

  • Manoussakis, M. N., C. Georgopoulou, E. Zintzaras, M. Spyropoulou, A. Stavropoulou, F. N. Skopouli, H. M. Moutsopoulos (2004) Sjogren’s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren’s syndrome. Arthritis Rheum 50(3):882–891

    Article  PubMed  Google Scholar 

  • Marriette, X. (2003) Lack of benefit of Infliximab in Sjogren’s Syndrome. Arth Rhem abstract S19

    Google Scholar 

  • McClain, M. T., L. D. Heinlen, G. J. Dennis, J. Roebuck, J. B. Harley, J. A. James (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11(1):85–89

    Article  PubMed  CAS  Google Scholar 

  • Merkel, P. A., Y. Chang, S. S. Pierangeli, K. Convery, E. N. Harris, R. P. Polisson (1996) The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 101(6):576–583

    Article  PubMed  CAS  Google Scholar 

  • Merkel, P. A., R. P. Polisson, Y. Chang, S. J. Skates, J. L. Niles (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126(11):866–873

    PubMed  CAS  Google Scholar 

  • Mikulicz, J.H. (1892) Uber eine eigenartige symmetrische Erkrankung der Tranen-und Mundspeicheldrusen. In Beitr. Chir. Fortschr., edited by G. T. Billroth. Stuttgart

    Google Scholar 

  • Millard, L. G., N. R. Rowell (1978) Chilblain lupus erythematosus (Hutchinson) A CLINICAL AND LABORATORY STUDY OF 17 PATIENTS. British Journal of Dermatology 98(5):497–506

    Article  PubMed  CAS  Google Scholar 

  • Miyagawa, S., T. Iida, T. Fukumoto, T. Matsunaga, A. Yoshioka, T. Shirai (1995) Anti-Ro/SSA-associated annular erythema in childhood. Br J Dermatol 133(5):779–782

    Article  PubMed  CAS  Google Scholar 

  • Morgan, W., B Castleman (1953) A clinicopathologic study of Mikulicz’a disease. Am J Pathol 29:471–503

    PubMed  CAS  Google Scholar 

  • Mori, K., M. Iijima, H. Koike, N. Hattori, F. Tanaka, H. Watanabe, M. Katsuno, A. Fujita, I. Aiba, A. Ogata, T. Saito, K. Asakura, M. Yoshida, M. Hirayama, G. Sobue (2005) The wide spectrum of clinical manifestations in Sjogren’s syndrome-associated neuropathy. Brain 128(Pt 11):2518–2534

    Article  PubMed  Google Scholar 

  • Musadiq, M., S. Mukherji, S. Sandramouli (2005) Pyogenic granuloma following silicone punctal plugs: report of two cases. Orbit 24(2):149–151

    Article  PubMed  CAS  Google Scholar 

  • Nakamura, H., A. Kawakami, M. Tominaga, A. Hida, S. Yamasaki, K. Migita, Y. Kawabe, T. Nakamura, K. Eguchi (2000) Relationship between Sjogren’s syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients [In Process Citation]. J Lab Clin Med 135(2): 139–144

    Article  PubMed  CAS  Google Scholar 

  • Navarro, M., R. Cervera, J. Font, J. C. Reverter, J. Monteagudo, G. Escolar, A. Lopez-Soto, A. Ordinas, M. Ingelmo (1997) Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 6(6):521–526

    Article  PubMed  CAS  Google Scholar 

  • Nishimagi, E., Y. Kawaguchi, C. Terai, H. Kajiyama, M. Hara, N. Kamatani (2001) Progressive interstitial renal fibrosis due to Chinese herbs in a patient with calcinosis Raynaud esophageal sclerodactyly telangiectasia (CREST) syndrome. Intern Med 40(10):1059–1063

    Article  PubMed  CAS  Google Scholar 

  • Nishimori, I., K. Okazaki, Y. Yamamoto, M. Morita, S. Tamura, Y. Yamamoto (1993) Specific cellular immune responses to pancreatic antigen in chronic pancreatitis and Sjögren’s syndrome. J Clin Immunol 13(4):265–271

    Article  PubMed  CAS  Google Scholar 

  • Nishimura, M., S. Miyajima, N. Okada (2000) Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjogren’s Syndrome [In Process Citation]. J Dermatol 27(7):450–452

    PubMed  CAS  Google Scholar 

  • O’Donnell, B., A. K. Black (1995) Urticarial vasculitis. Int Angiol 14(2):166–174

    PubMed  Google Scholar 

  • Ogawa, N., L. Ping, L. Zhenjun, Y. Takada, S. Sugai (2002) Involvement of the interferon-gammainduced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren’s syndrome. Arthritis Rheum 46(10):2730–2741

    Article  PubMed  CAS  Google Scholar 

  • Pablos, J. L., V. Cogolludo, F. Pinedo, P. E. Carreira (1993) Subcutaneous nodular amyloidosis in Sjögren’s syndrome. Scandinavian journal of rheumatology 22:250–251

    Article  PubMed  CAS  Google Scholar 

  • Papas, A. S., A. Joshi, S. L. MacDonald, L. Maravelis-Splagounias, P. Pretara-Spanedda, F. A. Curro (1993) Caries prevalence in xerostomic individuals. J Can Dent Assoc 59(2):171–174, 7–9

    PubMed  CAS  Google Scholar 

  • Papas, A. S., A. Joshi, A. J. Belanger, R. L. Kent, Jr., C. A. Palmer, P. F. DePaola (1995) Dietary models for root caries. Am J Clin Nutr 61(2):417S–422S

    PubMed  CAS  Google Scholar 

  • Papas, A. S., A. Joshi, C. A. Palmer, J. L. Giunta, J. T. Dwyer (1995) Relationship of diet to root caries. Am J Clin Nutr 61(2):423S–429S

    PubMed  CAS  Google Scholar 

  • Papas, A. S., M. M. Fernandez, R. A. Castano, S. C. Gallagher, M. Trivedi, R. C. Shrotriya (1998) Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjogrens syndrome. Adv Exp Med Biol 438:973–978

    PubMed  CAS  Google Scholar 

  • Pease, C. T., W. Shattles, N. K. Barrett, R. N. Maini (1993) The arthropathy of Sjogren’s syndrome. Br J Rheumatol 32(7):609–613

    Article  PubMed  CAS  Google Scholar 

  • Pender, M. P. (1999) Recent progress in the diagnosis and treatment of multiple sclerosis. J Clin Neurosci 6(5):367–372

    Article  PubMed  CAS  Google Scholar 

  • Perez, B., A. Kraus, G. Lopez, M. Cifuentes, D. Alarcon-Segovia (1995) Autoimmune thyroid disease in primary Sjogren’s syndrome. Am J Med 99(5):480–484

    Article  PubMed  CAS  Google Scholar 

  • Pers, J. O., F. d’Arbonneau, V. Devauchelle-Pensec, A. Saraux, Y. L. Pennec, P. Youinou (2005) Is periodontal disease mediated by salivary baff in sjogren’s syndrome? Arthritis Rheum 52(8):2411–2414

    Article  PubMed  Google Scholar 

  • Pers, J. O., C. Daridon, V. Devauchelle, S. Jousse, A. Saraux, C. Jamin, P. Youinou (2005) BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases. Ann N Y Acad Sci 1050:34–39

    Article  PubMed  CAS  Google Scholar 

  • Petrone, D., J. J. Condemi, R. Fife, O. Gluck, S. Cohen, P. Dalgin (2002) A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren’s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 46(3):748–754

    Article  PubMed  CAS  Google Scholar 

  • Pflugfelder, S. C. (1996) Differential diagnosis of dry eye conditions. Adv Dent Res 10(1):9–12

    Article  PubMed  CAS  Google Scholar 

  • Pflugfelder, S. C. (2004) Antiinflammatory therapy for dry eye. Am J Ophthalmol 137(2):337–342

    Article  PubMed  Google Scholar 

  • Pillemer, S. R., E. L. Matteson, L. T. Jacobsson, P. B. Martens, L. J. Melton, 3rd, W. M. O’Fallon, P. C. Fox (2001) Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 76(6):593–599

    Article  PubMed  CAS  Google Scholar 

  • Pirildar, T., C. Tikiz, S. Ozkaya, S. Tarhan, O. Utuk, H. Tikiz, U. K. Tezcan (2005) Endothelial dysfunction in patients with primary Sjogren’s syndrome. Rheumatology international 25(7):536–539

    Article  PubMed  Google Scholar 

  • Press, J., Y. Uziel, R. M. Laxer, L. Luy, R. M. Hamilton, E. D. Silverman (1996) Long-term outcome of mothers of children with complete congenital heart block. Am J Med 100(3):328–332

    Article  PubMed  CAS  Google Scholar 

  • Price, E. J., S. P. Rigby, U. Clancy, P. J. Venables (1998) A double blind placebo controlled trial of azathioprine in the treatment of primary Sjogren’s syndrome. J Rheumatol 25(5):896–899

    PubMed  CAS  Google Scholar 

  • Provost, T. T., R. Watson (1992) Cutaneous manifestations of Sjogren’s syndrome. Rheum Dis Clin North Am 18(3):609–616

    PubMed  CAS  Google Scholar 

  • Provost, T. T., R. Watson, O. Brien E. Simmons (1997) Anti-Ro(SS-A) antibody positive Sjogren’s/ lupus erythematosus overlap syndrome. Lupus 6(2): 105–111

    Article  PubMed  CAS  Google Scholar 

  • Provost, T. T., R. Watson, E. Simmons-O’Brien (1997) Anti-Ro(SS-A) antibody positive Sjogren’s/ lupus erythematosus overlap syndrome. Lupus 6(2): 105–111

    Article  PubMed  CAS  Google Scholar 

  • Quismorio, F. P., Jr. (1996) Pulmonary involvement in primary Sjogren’s syndrome. Curr Opin Pulm Med 2(5):424–428

    Article  PubMed  Google Scholar 

  • Rader, M.D., C. O’Brien, Y. Liu, J.B. Harley, M. Reichlin (1989) Heterogeneity of the Ro/SSA antigen. J. Clin. Invest. 83:1293–1298

    Article  PubMed  CAS  Google Scholar 

  • Raderer, M., C. Osterreicher, K. Machold, M. Formanek, W. Fiebiger, M. Penz, B. Dragosics, A. Chott (2001) Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease. Ann Oncol 12(7):937–939

    Article  PubMed  CAS  Google Scholar 

  • Radfar, L., D. E. Kleiner, P. C. Fox, S. R. Pillemer (2002) Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. Arthritis Rheum 47(5):520–524

    Article  PubMed  Google Scholar 

  • Ramos-Casals, M., J. M. Anaya, M. Garcia-Carrasco, J. Rosas, A. Bove, G. Claver, L. A. Diaz, C. Herrero, J. Font (2004) Cutaneous vasculitis in primary Sjogren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 83(2):96–106

    Article  Google Scholar 

  • Ramos-Casals, M., R. Cervera, J. Yague, M. Garcia-Carrasco, O. Trejo, S. Jimenez, R. M. Morla, J. Font, M. Ingelmo (1998) Cryoglobulinemia in primary Sjogren’s syndrome: prevalence and clinical characteristics in a series of 115 patients. Semin Arthritis Rheum 28(3):200–205

    Article  PubMed  CAS  Google Scholar 

  • Robinson, C. P., H. Yamamoto, A. B. Peck, M. G. Humphreys-Beher (1996) Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice. Clin Immunol Immunopathol 79(1):50–59

    Article  PubMed  CAS  Google Scholar 

  • Robinson, C., S. Yamciuka, C. Alford, C. Cooper, E. Pichardo, N. Shah, M. Peck, M. Humphrey-Beher (1997) Elevated levels of cysteine protease activity in saliva and salivary glands of NOD mouse model for Sjogren’s syndrome. Proc Nat Acad Sci 94:5767–5771

    Article  PubMed  CAS  Google Scholar 

  • Roguedas, A. M., L. Misery, B. Sassolas, G. Le Masson, Y. L. Pennec, P. Youinou (2004) Cutaneous manifestations of primary Sjogren’s syndrome are underestimated. Clin Exp Rheumatol 22(5):632–636

    PubMed  CAS  Google Scholar 

  • Rosler, D. H., M. D. Conway, J. M. Anaya, J. F. Molina, R. F. Carr, A. E. Gharavi, W. A. Wilson (1995) Ischemic optic neuropathy and high-level anticardiolipin antibodies in primary Sjogren’s syndrome. Lupus 4(2):155–157

    Article  PubMed  CAS  Google Scholar 

  • Royer, B., D. Cazals-Hatem, J. Sibilia, F. Agbalika, J. M. Cayuela, T. Soussi, F. Maloisel, J. P. Clauvel, J. C. Brouet, X. Mariette (1997) Lymphomas in patients with Sjogren’s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 90(2):766–775

    PubMed  CAS  Google Scholar 

  • Rustin, M. H. A., J. A. Newton, N. P. Smith, P. M. Dowd (1989) The treatment of chilblains with nifedipine: the results of a pilot study, a double-blind placebo-controlled randomized study and a long-term open trial. British Journal of Dermatology 120(2):267–275

    Article  PubMed  CAS  Google Scholar 

  • Ruzicka, T., J. Faes, T. Bergner, R. U. Peter, O. Braun-Falco (1991) Annular erythema associated with Sjogren’s syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol 25(3):557–560

    Article  PubMed  CAS  Google Scholar 

  • Sais, G., C. Admella, M. J. Fantova, J. C. Montero (1998) Lymphocytic autoimmune hidradenitis, cutaneous leucocytoclastic vasculitis and primary Sjogren’s syndrome. Br J Dermatol 139(6): 1073–1076

    Article  PubMed  CAS  Google Scholar 

  • Salaffi, F., G. Argalia, M. Carotti, F. B. Giannini, C. Palombi (2000) Salivary gland ultrasonography in the evaluation of primary Sjogren’s syndrome. Comparison with minor salivary gland biopsy. J Rheumatol 27(5):1229–1236

    PubMed  CAS  Google Scholar 

  • Sall, K, OD Stevenson, TK Mundorf, BL Reis (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107(4):631

    Article  PubMed  CAS  Google Scholar 

  • Sankar, V., M. T. Brennan, M. R. Kok, R. A. Leakan, J. A. Smith, J. Manny, B. J. Baum, S. R. Pillemer (2004) Etanercept in Sjogren’s syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum 50(7):2240–2245

    Article  PubMed  CAS  Google Scholar 

  • Santiago-Raber, M. L., R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart, D. H. Kono, A. N. Theofilopoulos (2003) Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 197(6):777–788

    Article  PubMed  CAS  Google Scholar 

  • Sawalha, A. H., R. Potts, W. R. Schmid, R. H. Scofield, J. B. Harley (2003) The genetics of primary Sjogren’s syndrome. Curr Rheumatol Rep 5(4):324–332

    Article  PubMed  Google Scholar 

  • Schiodt, M., L. B. Christensen, P. E. Petersen, J. J. Thorn (2001) Periodontal disease in primary Sjogren’s syndrome. Oral Dis 7(2): 106–108

    PubMed  CAS  Google Scholar 

  • Scofield, R. H., B. T. Kurien, F. Zhang, P. Mehta, K. Kaufman, T. Gross, M. Bachmann, T. Gordon, J. B. Harley (1999) Protein-protein interaction of the Ro-ribonucleoprotein particle using multiple antigenic peptides [In Process Citation]. Mol Immunol 36(15–16):1093–1106

    Article  PubMed  CAS  Google Scholar 

  • Sestak, A.L., J.B. Harley, S. Yoshida, M. Reichlin (1987) Lupus/Sjögren’s autoantibody specificities in sera with paraproteins. J. Clin. Invest. 80:138–144

    Article  PubMed  CAS  Google Scholar 

  • Sheikh, S. H., T. A. Shaw-Stiffel (1995) The gastrointestinal manifestations of Sjogren’s syndrome. Am J Gastroenterol 90(1):9–14

    PubMed  CAS  Google Scholar 

  • Shibata, S., Y. Ubara, N. Sawa, T. Tagami, J. Hosino, M. Yokota, H. Katori, F. Takemoto, S. Hara, K. Takaichi, A. Fujii, H. Murata, T. Nishi (2004) Severe interstitial cystitis associated with Sjogren’s syndrome. Intern Med 43(3):248–252

    Article  PubMed  Google Scholar 

  • Siamopoulos, K. C., M. Elisaf, H. M. Moutsopoulos (1994) Hypokalaemic paralysis as the presenting manifestation of primary Sjogren’s syndrome. Nephrol Dial Transplant 9(8): 1176–1178

    PubMed  CAS  Google Scholar 

  • Simmons-O’Brien, E., S. Chen, R. Watson, C. Antoni, M. Petri, M. Hochberg, M. B. Stevens, T. T. Provost (1995) One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine (Baltimore) 74(3): 109–130

    Article  Google Scholar 

  • Skopouli, F. N., P. Jagiello, N. Tsifetaki, H. M. Moutsopoulos (1996) Methotrexate in primary Sjogren’s syndrome. Clin Exp Rheumatol 14(5):555–558

    PubMed  CAS  Google Scholar 

  • Soto-Rojas, A. E., A. Kraus (2002) The oral side of sjogren syndrome. Diagnosis and treatment. A review. Arch Med Res 33(2):95–106

    Article  PubMed  Google Scholar 

  • Spezialetti, R., H. G. Bluestein, J. B. Peter, E. L. Alexander (1993) Neuropsychiatric disease in Sjogren’s syndrome: anti-ribosomal P and anti-neuronal antibodies. Am J Med 95(2):153–160

    Article  PubMed  CAS  Google Scholar 

  • Steinfeld, S. D., P. Demols, I. Salmon, R. Kiss, T. Appelboom (2001) Infliximab in patients with primary Sjogren’s syndrome: a pilot study. Arthritis Rheum 44(10):2371–2375

    Article  PubMed  CAS  Google Scholar 

  • Stern, M. E., R. W. Beuerman, R. I. Fox, J. Gao, A. K. Mircheff, S. C. Pflugfelder (1998) A unified theory of the role of the ocular surface in dry eye. Adv Exp Med Biol 438:643–651

    PubMed  CAS  Google Scholar 

  • Strong, B., W. Farley, M. E. Stern, S. C. Pflugfelder (2005) Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea 24(1):80–85

    Article  PubMed  Google Scholar 

  • Suzuki, K., M. Matsumoto, M. Nakashima, K. Takada, T. Nakanishi, M. Okada, F. Ohsuzu (2005) Effect of cevimeline on salivary components in patients with Sjogren syndrome. Pharmacology 74(2): 100–105

    Article  PubMed  CAS  Google Scholar 

  • Swords, R., D. Power, M. Fay, R. O’Donnell, P. T. Murphy (2004) Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP). Am J Hematol 77(1): 103–104

    Article  PubMed  CAS  Google Scholar 

  • Takeda, K., T. Kaisho, S. Akira (2003) Toll-like receptors. Annu Rev Immunol 21:335–376

    Article  PubMed  CAS  Google Scholar 

  • Tan, E. M., T. E. Feltkamp, J. S. Smolen, B. Butcher, R. Dawkins, M. J. Fritzler, T. Gordon, J. A. Hardin, J. R. Kalden, R. G. Lahita, R. N. Maini, J. S. McDougal, N. F. Rothfield, R. J. Smeenk, Y. Takasaki, A. Wiik, M. R. Wilson, J. A. Koziol (1997) Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 40(9):1601–1611

    Article  PubMed  CAS  Google Scholar 

  • Tapinos, N. I., M. Polihronis, A. G. Tzioufas, H. M. Moutsopoulos (1999) Sjogren’s syndrome. Autoimmune epithelitis. Adv Exp Med Biol 455:127–134

    PubMed  CAS  Google Scholar 

  • Tatlipinar, S., E. K. Akpek (2005) Topical ciclosporin in the treatment of ocular surface disorders. Br J Ophthalmol 89(10):1363–1367

    Article  PubMed  CAS  Google Scholar 

  • Tektonidou, M. G., M. Anapliotou, P. Vlachoyiannopoulos, H. M. Moutsopoulos (2004) Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis 63(9):1159–1161

    Article  PubMed  CAS  Google Scholar 

  • Tektonidou, M., E. Kaskani, F. N. Skopouli, H. M. Moutsopoulos (1999) Microvascular abnormalities in Sjogren’s syndrome: nailfold capillaroscopy. Rheumatology (Oxford) 38(9):826–830

    Article  CAS  Google Scholar 

  • Tensing, E. K., S. A. Solovieva, T. Tervahartiala, D. C. Nordstrom, M. Laine, S. Niissalo, Y. T. Konttinen (2001) Fatigue and health profile in sicca syndrome of Sjogren’s and non-Sjogren’s syndrome origin. Clin Exp Rheumatol 19(3):313–316

    PubMed  CAS  Google Scholar 

  • Tishler, M., I. Alosachie, N. Barka, H. C. Lin, M. E. Gershwin, J. B. Peter, Y. Shoenfeld (1995) Primary Sjogren’s syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin Exp Rheumatol 13(4):497–500

    PubMed  CAS  Google Scholar 

  • Tishler, M., Y. Barak, D. Paran, M. Yaron (1997) Sleep disturbances, fibromyalgia and primary Sjogren’s syndrome. Clin Exp Rheumatol 15(1):71–74

    PubMed  CAS  Google Scholar 

  • Tonami, H., K. Higashi, M. Matoba, H. Yokota, I. Yamamoto, S. Sugai (2001) A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjogren syndrome. J Comput Assist Tomogr 25(2):262–268

    Article  PubMed  CAS  Google Scholar 

  • Urban, P. P., A. Keilmann, E. M. Teichmann, H. C. Hopf (2001) Sensory neuropathy of the trigeminal, glossopharyngeal, and vagal nerves in Sjogren’s syndrome. J Neurol Sci 186(1–2):59–63

    Article  PubMed  CAS  Google Scholar 

  • Utset, T. O., M. Golden, G. Siberry, N. Kiri, R. M. Crum, M. Petri (1994) Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjogren’s syndrome. J Rheumatol 21(11):2039–2045

    PubMed  CAS  Google Scholar 

  • van Dam, A. P., E. M. Wekking, J. A. Callewaert, A. J. Schipperijn, H. A. Oomen, J. de Jong, A. J. Swaak, R. J. Smeenk, T. E. Feltkamp (1994) Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatology international 14(2):57–62

    Article  PubMed  Google Scholar 

  • Vitali, C. (2003) Classification criteria for Sjogren’s syndrome. Ann Rheum Dis 62(1):94–95; author reply 5

    Article  PubMed  CAS  Google Scholar 

  • Vitali, C., H. M. Moutsopoulos, S. Bombardieri (1994) The European Community Study Group on diagnostic criteria for Sjogren’s syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren’s syndrome. Ann Rheum Dis 53(10):637–647

    Article  PubMed  CAS  Google Scholar 

  • Vivino, F. B., I. Gala, G. A. Hermann (2002) Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 29(5):938–944

    PubMed  Google Scholar 

  • Voulgarelis, M., U. G. Dafni, D. A. Isenberg, H. M. Moutsopoulos (1999) Malignant lymphoma in primary Sjogren’s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren’s Syndrome. Arthritis Rheum 42(8):1765–1772

    Article  PubMed  CAS  Google Scholar 

  • Wall, G. C., M. L. Magarity, J. W. Jundt (2002) Pharmacotherapy of xerostomia in primary Sjogren’s syndrome. Pharmacotherapy 22(5):621–629

    Article  PubMed  CAS  Google Scholar 

  • Wallace, D. (1994) Antimalarial agents and lupus. Rheum Dis Clinics NA 20:243–263

    CAS  Google Scholar 

  • Wallace, D. J. 2002. Management of lupus erythematosus: recent insights. Curr Opin Rheumatol 14(3):212–219

    Google Scholar 

  • Watanabe, T., T. Tsuchida, M. Furue, S. Yoshinoya (1996) Annular erythema, dermatomyositis, and Sjogren’s syndrome. Int J Dermatol 35(4):285–287

    Article  PubMed  CAS  Google Scholar 

  • Watanabe, T., T. Tsuchida, Y. Ito, N. Kanda, Y. Ueda, K. Tamaki (1997) Annular erythema associated with lupus erythematosus/Sjogren’s syndrome. J Am Acad Dermatol 36:214–218

    Article  PubMed  CAS  Google Scholar 

  • Wu, A. J. (2003) The oral component of Sjogren’s syndrome: pass the scalpel and check the water. Curr Rheumatol Rep 5(4):304–310

    Article  PubMed  Google Scholar 

  • Wu, A. J., P. C. Fox (1994) Sjogren’s syndrome. Semin Dermatol 13(2):138–143

    PubMed  CAS  Google Scholar 

  • Yamamoto, H., K. Ishibashi, Y. Nakagawa, N. Maeda, T. Zeng, C. P. Robinson, G. E. Oxford, N. Chegini, M. G. Humphreys-Beher (1997) Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic mouse model for autoimmune sialoadenitis. Scand J Immunol 45(1):55–61

    Article  PubMed  CAS  Google Scholar 

  • Yamamoto, T., I. Katayama, K. Nishioka (1998) Analysis of T cell receptor Vbeta repertoires of annular erythema associated with Sjogren’s syndrome. Eur J Dermatol 8(4):248–251

    PubMed  CAS  Google Scholar 

  • Yoneyama, K., N. Tochigi, A. Oikawa, H. Shinkai, A. Utani (2005) Primary localized cutaneous nodular amyloidosis in a patient with Sjogren’s syndrome: a review of the literature. J Dermatol 32(2):120–123

    PubMed  Google Scholar 

  • Yousem, D. M., M. A. Kraut, A. A. Chalian (2000) Major salivary gland imaging. Radiology 216(1):19–29

    PubMed  CAS  Google Scholar 

  • Zandbelt, M. M., P. de Wilde, P. van Damme, C. B. Hoyng, L. van de Putte, F. van den Hoogen (2004) Etanercept in the treatment of patients with primary Sjogren’s syndrome: a pilot study. J Rheumatol 31(1):96–101

    PubMed  CAS  Google Scholar 

  • Zukowski, T. H., R. A. Jorgensen, E. R. Dickson, K. D. Lindor (1998) Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy. Am J Gastroenterol 93(6):958–961

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Michael Hertl

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag/Wien

About this chapter

Cite this chapter

Fox, R.I., Fox, C.M. (2011). Sjögren’s Syndrome. In: Hertl, M. (eds) Autoimmune Diseases of the Skin. Springer, Vienna. https://doi.org/10.1007/978-3-211-99225-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-99225-8_13

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-99224-1

  • Online ISBN: 978-3-211-99225-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics